The Ankylosing Spondylitis Market is the global market of the therapy, drugs, and solutions associated with ankylosing spondylitis which is an autoimmune inflammatory disease that primarily impacts the spine and sacroiliac joints. This entails; Biologic and small molecule therapeutics, else related services offered through various touch points including hospital systems, retail pharmacies, and direct-to-consumer internet. This market is growing at present due to the growing prevalence rates of this state and the availability of more effective targeted treatments.